Tuesday, May 13, 2025

News

Portugal Approves Esketamine for Severe Depression Treatment

Portugal has taken a significant step in mental health care by approving public funding for esketamine, a psychedelic drug used to treat severe depression. This decision, announced by Infarmed,...

Psilocybin-Assisted Therapy Shows Promise for Substance Use Disorders

A recent scientific review has examined the potential of psilocybin-assisted therapy (PAP) as a treatment for substance use disorders (SUDs), focusing on its impact...

Psychedelics May Disrupt Immune-Driven Fear Responses, Offering New Hope for Mental Health Treatment

A groundbreaking study from Mass General Brigham has unveiled a previously unknown connection between the immune system and the brain's fear response. The research...

VA Secretary Says Psychedelic Therapies Are Under Consideration

During a recent Cabinet meeting, U.S. Department of Veterans Affairs Secretary Doug Collins told President Donald Trump that the VA is actively exploring the...

California Senate Panel Advances Psilocybin Pilot Program for Veterans and First Responders

California senators have unanimously supported a bipartisan proposal aimed at establishing a psilocybin pilot program to support military veterans and first responders. The Senate Health...

Breathwork Gains Momentum as a Pathway to Altered States and Emotional Healing

Once rooted in ancient spiritual traditions, breathwork is now experiencing a modern revival as a tool for achieving altered states of consciousness and emotional...

Psychedelics Show Promise for Mental Health Treatment

Psychedelic drugs are once again capturing the spotlight, not for their mind-altering effects but for their promising role in mental health treatment. A new...

Microdosing Psychedelics Draws Attention from Researchers

Microdosing—taking small, non-hallucinogenic amounts of psychedelic substances—is rapidly becoming a wellness trend embraced by people from all walks of life. Rather than seeking intense...

Can Ketamine Treat Depression Without the Trip? Researchers Say Yes

Once known mostly as an anesthetic and later as a party drug, ketamine is now emerging as one of the most promising breakthroughs in...

San Francisco University Launches First-Ever Psychedelic Studies Degree in the U.S.

A university in San Francisco is breaking new ground with a bold addition to its academic offerings: a Bachelor of Science in Psychedelic Studies....

Arizona Pioneers First FDA-Approved Clinical Trials Using Whole Psilocybin Mushrooms

In a groundbreaking move, Arizona is on the verge of pioneering research into the effects of whole psilocybin mushrooms through human clinical trials. This...